PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

Dr Avi Chaudhuri appointed Systech Chief Scientist latest in a series of senior appointments by CEO Ara Ohanian

Dr. Avi Chaudhuri – Chief Scientist Systech

Princeton, NJ. March 7, 2019:Systech, global leader in supply chain security and brand protection, has announced the appointment of Dr Avi Chaudhuri to the newly created position of Chief Scientist. This is the latest in a series of senior leadership appointments by CEO Ara Ohanian.

Comments Systech CEO Ara Ohanian: “Industry is faced with increasingly complex counterfeit and supply chain diversion challenges. The need to fully exploit and communicate technology breakthroughs for the benefit of our clients is essential. In his new role, Dr Chaudhuri will harness and develop our tech potential and work with our technology and customer communities to deliver peerless brand protection. Dr Chaudhuri brings a very rare blend of powerful global scientific and business acumen – perfect casting for us and for our clients.”

Dr Chaudhuri assumes the new role in addition to his current position as Systech’s Senior Global Partner where he is responsible for spearheading Systech’s expansion in the Middle East, India and APAC. He reports directly to Systech CEO, Ara Ohanian, and the appointment is effective immediately.

About Dr Avi Chaudhuri

Dr Chaudhuri has designed and deployed serialization, traceability, and brand protection programs for some of the largest global companies. He is a strong public advocate of the need to protect consumers by evangelizing on the benefits of effective anti-counterfeiting technologies. He introduced the very concept of mass serialization to the Indian pharmaceutical industry twelve years ago and helped to create a national SMS program that allowed consumers to verify their drug purchase. He has authored several manuscripts and white papers on technology solutions to combat counterfeiting, which have had significant impact in shaping public policy and protecting consumers. Dr Chaudhuri holds a PhD in Neuroscience from the University of California, Berkeley. In addition to his work at Systech, he is Founder and Trustee of The Purnima Foundation in India.

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026